Website Genmark is a trusted leader in molecular diagnostics, dedicated to providing innovative solutions for accurate and efficient disease detection. With expertise in advanced diagnostic technologies, Genmark develops high-performance kits tailored for applications in oncology, genetics, microbiology, digital PCR, and veterinary diagnostics. Known for their precision, reliability, and ease of use, Genmark’s molecular diagnostic kits support healthcare providers and researchers in delivering better outcomes and advancing personalized medicine.We collaborate with Genmark to bring their geneMAP™ Molecular Diagnostic Kits to laboratories and healthcare providers. These cutting-edge kits are designed to deliver accurate, rapid, and reliable results for diverse applications:Oncology: Detection of genetic mutations and biomarkers associated with cancers, aiding in diagnosis and treatment strategies.Genetics: Identification of hereditary genetic variations, supporting personalized medicine and genetic counseling.Microbiology: Comprehensive assays for detecting pathogens, enhancing infectious disease diagnostics.Digital PCR: Advanced technology for precise quantification of nucleic acids, enabling detection of low-abundance targets.Veterinary Diagnostics: Specialized kits for diagnosing diseases in animals, supporting veterinary healthcare and zoonotic disease management.Genmark’s molecular diagnostic kits are known for their ease of use, high analytical performance, and versatility with various specimen types. By integrating Genmark’s products into our portfolio, Altium International ensures that laboratories and researchers have access to advanced diagnostic tools, empowering them to achieve excellence in molecular diagnostics.
The geneMAP™ 2019-nCoV (2019-nCoV) Detection Kit is qualitative in vitro assay (Multiplex qRT-PCR) for the detection of SARS-CoV-2 from Nasopharyngeal swab / Oropharyngeal swab for people with or without clinical symptom associated with COVID-19. Size: 500 tests
The geneMAP™ BCR-ABL1 Screening Kit is intended for detection of p190BCR-ABL1 (e1a2), p210BCR-ABL1 (b2a2 & b3a2) and p230BCR-ABL1 (e19a2) fusion transcripts in bone marrow or peripheral blood samples of patients who have been diagnosed with Acute Lymphoblastic Leukemia (ALL) or Chronic Myeloid Leukemia (CML). The Kit can distinguish between the p190 BCR-ABL1, p210 BCR-ABL1 &… Continue reading geneMAP™ BCR-ABL1 (p190, p210, p230) Screening Kit
The geneMAP™ BCR-ABL1 p190(mbcr) Detection Kit intended for the quantification of BCR-ABL1 p190(e1a2) transcripts in bone marrow or peripheral blood samples of Ph-positive acute lymphoblastic leukemia (ALL) patients previously diagnosed with a BCR-ABL1 mbcr fusion gene event. The test is intended to evaluate the level of molecular response. This test can be used to monitor… Continue reading geneMAP™ BCR-ABL1 p190 (mbcr) Detection Kit
The geneMAP™ BCR-ABL1 p210 IS-MMR Kit is intended for the quantitative detection of BCR-ABL1 p210 b2a2 and b3a2 fusion transcripts in bone marrow or peripheral blood samples of patients who have been diagnosed with Acute Lymphoblastic Leukemia (ALL) or Chronic Myeloid Leukemia (CML). This test can be used to monitor Minimal Residual Disease (MRD) in… Continue reading geneMAP™ BCR-ABL1 p210(Mbcr) IS-MMR Detection Kit
geneMAP™ BCR-ABL1 p230 (μbcr) Detection Kit for Leukemia are intended for the quantitative detection of micro BCR-ABL1(p230) e19a2, fusion transcripts in bone marrow or peripheral blood samples. The results obtained are intended to be used as an aid to monitor efficacy of treatment in patients undergoing therapy, and for minimal residual disease (MRD) follow-up to… Continue reading geneMAP™ BCR-ABL1 p230 (μbcr) Detection Kit
Lyme borreliosis is a systemic disease caused by infection with the spirochete Borrelia burgdorferi. It is currently the most common arthropod-borne disease in the United States, and thousands of cases are reported to the Centers for Disease Control and Prevention every year. At least three genospecific pathogens have been characterized in humans: B. burgdorferi sensu stricto, B. afzelii and B. garinii.… Continue reading geneMAP™ Borrelia Detection Kit
The geneMAP™ BRCA1&2 Founder Mutations Detection Kit is an Allele Specific Realtime PCR (Aso-Realtime PCR) assay desig- ned to detect 8 mutations in the BRCA1 gene and 1 mutation in the BRCA2 gene in the genomic DNA of blood or buccal swab samples. The kit detects 4153delA, 185delAG, 2080delA, 300 T>G (Cys61Gly), 5382insC, 3819delGTAAA, 3875delGTCT… Continue reading geneMAP™ BRCA1&2 Founder Mutations Detection Kit
In the majority of cases of systemic mastocytosis, the accumulated mast cells have a mutation in the KIT gene. In more than 80 percent of individuals with systemic mastocytosis, the amino acid at position 816 (aspartic acid) is replaced by valine as a result of the mutation. geneMAP™ c-KIT D816V Mutation Detection Kit can distinguish… Continue reading geneMAP™ c-KIT D816V Mutation Detection Kit
The geneMAP™ CALR Screening Kit is a qualitative in vitro assay for the detection of 36 CALR somatic mutations from human genomic DNA of subjects suspected of myeloproliferative neoplasms (MPN) and also allows the identification of the two major CALR mutations (Type 1 and Type 2). Size: 24 tests
geneMAP™ CBFB-MYH11 Inv(16) Detection Kit for Leukemia are intended for the quantitative detection of CBFB-MYH11, fusion transcripts in bone marrow or peripheral blood samples. The results obtained are intended to be used as an aid to monitor efficacy of treatment in patients undergoing therapy, and for minimal residual disease (MRD) follow-up to monitor disease relapse.… Continue reading geneMAP™ CBFB-MYH11 Inv(16) Detection Kit
Size: 50 tests
The geneMAP™ Celiac (DQ2, DQ8, DR4) Detection Kit can detect HLA-DQ2, HLA-DQ8 Heterodimers and HLA-DR4 Allele in Human Genomic DNA. Celiac disease is a common, familial, autoimmune gastrointestinal disease. It is caused by sensitivity to the dietary protein gluten, which is present in wheat, rye, and barley. Celiac disease has a strong genetic association with… Continue reading geneMAP™ Celiac (DQ2, DQ8, DR4) Detection Kit
Dihydropyrimidine dehydrogenase (DPD) is an enzyme encoded by the DPYD gene and is involved in the metabolism of fluoropy- rimidines, chemotherapeutics used in the treatment of some solid tumors. These drugs can cause severe gastrointestinal and hematologic toxicities due to the presence of certain mutations of the DPYD gene that determine the reduced activity of… Continue reading geneMAP™ DPYD Mutations Detection Kit
The geneMAP™ FII Mutation Detection Kit is a rapid and accurate, real-time PCR-based assay for the detection of the 20210G>A mutation in the human Factor II (F2) gene encoding the clotting factor prothrombin (PTH). This point mutation is associated with inherited thrombophilia. The kit is designed to identify patients at risk of venous thromboembolism. The… Continue reading geneMAP™ FII Mutation Detection Kit
The geneMAP™ FIP1L1-PDGFRA Detection Kit is intended for detection and quatitation of FIP1L1 exon 9/PDGFRA exon 12, FIP1L1 exon 10/PDGFRA exon 12, FIP1L1 exon11/PDGFRA exon 12, FIPL1 exon 12/PDGFRA exon 12 & FIPL1 exon 13/PDGFRA exon 12 fusion transcripts in bone marrow or peripheral blood samples of patients who have been diagnosed with idiopathic hypereosinophilic… Continue reading geneMAP™ FIP1L1-PDGFRA Detection Kit
Acute Myeloid Leukemia (AML) is the most common form of leukemia in adults and FLT3 activating mutations are expected to be present in 1 in 3 people diagnosed with AML. The presence of FLT3 activating mutations in AML indicates a poor prognosis and some treatment regimens and targeted drug trials are only accessible to patients… Continue reading geneMAP™ FLT3 D835Y Mutation Detection Kit
In order to access Altium products and services, we kindly ask you to select the country you want to receive service from.
Instead, to go to the Altium Global page, where you can get information about Altium in addition to the products and services we offer in countries;
